Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/BMY
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Bristol-Myers Squibb Co (BMY) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bristol Myers Squibb (BMY) trades at $62.71, down 1.4% on the day, with a bullish technical signal despite recent weakness. The stock shows strong fundamentals with a P/E of 13.84, net income margin of 18.87%, and consistent earnings beats in recent quarters. Recent positive clinical trial results for Sotyktu and arlocabtagene autoleucel highlight pipeline progress, while the company maintains a solid dividend yield.
BMY presents a compelling value opportunity with attractive valuation metrics and strong profitability, though patent expirations and debt levels pose risks. Analyst consensus targets $70.00 with 48% buy ratings, suggesting 12% upside potential. The company's growth portfolio now represents 58% of revenue, offsetting legacy product declines.
Read full analysis

Key Stats

  • Market Cap
    $128.36B
  • Volume
    12,132,088
  • Sector
    Health
  • 52W High
    $68.09
  • 52W Low
    $42.60
  • Typical Hold Time
    93 Days
  • Enterprise Value
    $162.35B
  • Div Yield
    4.01%
  • Trading Activity
    100% Sell | 0% Buy
$63.18
52W Low: $42.6
29 Oct 2025
52W High: $68.09
03 Sep 2026

Track Bristol-Myers Squibb Co (BMY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bristol-Myers Squibb Co has traded between a low of $42.6 and a high of $68.09, highlighting its annual price range. Buy and sell Bristol-Myers Squibb Co shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Bristol-Myers Squibb Co

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Most Recent News

Content is generated by Aura AI

On Holding enters football market with Kylian Mbappé partnership, shares volatile despite 'Underperform' rating.

On Holding, a Swiss athletic shoe company, is expanding into the global football market by partnering with soccer star Kylian Mbappé, who leaves Nike after nearly 20 years. This marks On Holding's first venture into football cleats and apparel, lever...

Market News
3 hours ago
Rayan Ahmad
Neutral
On Holding enters football market with Kylian Mbappé partnership, shares volatile despite 'Underperform' rating.

Peter Thiel's fund re-enters market with $419M, heavily investing 72% in energy and power sectors.

Peter Thiel's investment fund, which held no stocks for two consecutive quarters, has made a significant comeback with $419 million in new investments. Notably, 72% of this capital has been allocated to the energy and power sectors, signaling a strat...

Market News
4 hours ago
John Ballard
Bullish
news icon
Peter Thiel's fund re-enters market with $419M, heavily investing 72% in energy and power sectors.

Vanguard FTSE All-World ex-US ETF offers strong value with 12.5x P/E and 8% earnings yield, supported by AI-driven growth in Asia.

The Vanguard FTSE All-World ex-US ETF (VEU) currently trades at a compelling valuation of about 12.5 times price-to-earnings with an 8% earnings yield, outperforming the SPY year-to-date despite a stronger dollar. Its broad diversification, solid mom...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
Vanguard FTSE All-World ex-US ETF offers strong value with 12.5x P/E and 8% earnings yield, supported by AI-driven growth in Asia.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $128.36B
  • Volume
    12,132,088
  • Sector
    Health
  • 52W High
    $68.09
  • 52W Low
    $42.60
  • Typical Hold Time
    93 Days
  • Enterprise Value
    $162.35B
  • Div Yield
    4.01%
  • Trading Activity
    100% Sell | 0% Buy
$63.18
52W Low: $42.6
29 Oct 2025
52W High: $68.09
03 Sep 2026

Track Bristol-Myers Squibb Co (BMY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bristol-Myers Squibb Co has traded between a low of $42.6 and a high of $68.09, highlighting its annual price range. Buy and sell Bristol-Myers Squibb Co shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!